UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Symmetry tristable stochastic resonance induced by parameter under levy noise background

The European physical journal. B, Condensed matter physics, 2019-08, Vol.92 (8), p.1-8, Article 168

2019

Volltextzugriff (PDF)

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Nature medicine, 2021-11, Vol.27 (11), p.1904-1909

2021

Volltextzugriff (PDF)

Clinical practice guidelines for the diagnosis and treatment of inflammatory breast cancer: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2022

Chinese medical journal, 2023-08, Vol.136 (16), p.1894-1896

2023

Volltextzugriff (PDF)

Exosome miR‐134‐5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1

The journal of obstetrics and gynaecology research, 2021-11, Vol.47 (11), p.4037-4048

2021

Volltextzugriff (PDF)

The beneficial role of Asian-based RecurIndex test in the prognostic prediction in Chinese male breast cancer patients

Scientific reports, 2021-04, Vol.11 (1), p.7657-7657, Article 7657

2021

Volltextzugriff (PDF)

Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province

Scientific reports, 2023-02, Vol.13 (1), p.3370-3370, Article 3370

2023

Volltextzugriff (PDF)

Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial

BMC medicine, 2022-12, Vol.20 (1), p.498-10, Article 498

2022

Volltextzugriff (PDF)

Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer

Frontiers in immunology, 2024-04, Vol.15, p.1390261

2024

Volltextzugriff (PDF)

Metastasis patterns and prognosis in young breast cancer patients: A SEER database analysis

Frontiers in oncology, 2022-10, Vol.12, p.872862-872862

2022

Volltextzugriff (PDF)

Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)

Chinese medical journal, 2022-07, Vol.135 (14), p.1753-1755

2022

Volltextzugriff (PDF)

Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study

Chinese medical journal, 2024-06, Vol.137 (11), p.1369-1371

2024

Volltextzugriff (PDF)

Adjuvant chemotherapy and survival outcomes in older women with HR+/HER2− breast cancer: a propensity score-matched retrospective cohort study using the SEER database

BMJ open, 2024-03, Vol.14 (3), p.e078782-e078782

2024

Volltextzugriff (PDF)

A retrospective analysis of the InterTan nail and proximal femoral nail anti-rotation-Asia in the treatment of unstable intertrochanteric femur fractures in the elderly

Journal of orthopaedic surgery and research, 2016-01, Vol.11 (9), p.10-10, Article 10

2016

Volltextzugriff (PDF)

HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial

Nature communications, 2024-06, Vol.15 (1), p.5158-10

2024

Volltextzugriff (PDF)

Survival outcomes of autologous breast reconstruction after mastectomy: A matched case-control study

Frontiers in oncology, 2023-01, Vol.12, p.1022925-1022925

2023

Volltextzugriff (PDF)

Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231156146-17588359231156146

2023

Volltextzugriff (PDF)

Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?

Breast (Edinburgh), 2024-02, Vol.73, p.103671-103671, Article 103671

2024

Volltextzugriff (PDF)

Traction power systems for electrified railways: evolution, state of the art, and future trends

Railway Engineering Science (Online), 2024-03, Vol.32 (1), p.1-19

2024

Volltextzugriff (PDF)

A large single-center prospective study to investigate the factors influencing the choice of breast-conserving surgery versus mastectomy in Chinese women with early breast cancer

World journal of surgical oncology, 2023-02, Vol.21 (1), p.43-43, Article 43

2023

Volltextzugriff (PDF)

The value of hsa_circ_0058514 in plasma extracellular vesicles for breast cancer

Frontiers in oncology, 2022-11, Vol.12, p.995196-995196

2022

Volltextzugriff (PDF)

Multi-functional properties of lactic acid bacteria strains derived from canine feces

Frontiers in veterinary science, 2024-08, Vol.11, p.1404580

2024

Volltextzugriff (PDF)

A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)

Frontiers in oncology, 2024, Vol.14, p.1326385-1326385

2024

Volltextzugriff (PDF)

Hsa_circ_0002496 promotes the growth, angiogenesis, and stemness of breast cancer cells via miR‐433‐3p/YWHAZ cascade

Thoracic cancer, 2023-06, Vol.14 (18), p.1732-1741

2023

Volltextzugriff (PDF)

Disitamab vedotin, a HER2‐directed antibody‐drug conjugate, in patients with HER2‐overexpression and HER2‐low advanced breast cancer: a phase I/Ib study

Cancer communications (London, England), 2024-07, Vol.44 (7), p.833-851

2024

Volltextzugriff (PDF)

Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020

EClinicalMedicine, 2020-09, Vol.26, p.100503-100503, Article 100503

2020

Volltextzugriff (PDF)

1 – 25 von 499

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(403)
Mit Volltextzugriff
(424)

Publikationsform

Sprache

Englisch
(492)
Japanisch
(20)
Chinesisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(359)
Life Sciences & Biomedicine
(197)
Technology
(123)
Physical Sciences
(87)
Engineering
(82)
Humans
(59)
Environmental Sciences
(51)
Environmental Sciences & Ecology
(51)
Engineering, Electrical & Electronic
(45)
Breast Cancer
(41)
Oncology
(40)
Female
(39)
Chemistry
(35)
Optics
(33)
Computer Science
(30)
Robotics
(29)
Automation & Control Systems
(25)
Science & Technology - Other Topics
(25)
Physics
(24)
Materials Science
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Symmetry tristable stochastic resonance induced by parameter under levy noise background

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Clinical practice guidelines for the diagnosis and treatment of inflammatory breast cancer: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2022

Exosome miR‐134‐5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1

The beneficial role of Asian-based RecurIndex test in the prognostic prediction in Chinese male breast cancer patients

Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province

Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial

Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer

Metastasis patterns and prognosis in young breast cancer patients: A SEER database analysis

Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)

Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study

Adjuvant chemotherapy and survival outcomes in older women with HR+/HER2− breast cancer: a propensity score-matched retrospective cohort study using the SEER database

A retrospective analysis of the InterTan nail and proximal femoral nail anti-rotation-Asia in the treatment of unstable intertrochanteric femur fractures in the elderly

HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial

Survival outcomes of autologous breast reconstruction after mastectomy: A matched case-control study

Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)

Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?

Traction power systems for electrified railways: evolution, state of the art, and future trends

A large single-center prospective study to investigate the factors influencing the choice of breast-conserving surgery versus mastectomy in Chinese women with early breast cancer

The value of hsa_circ_0058514 in plasma extracellular vesicles for breast cancer

Multi-functional properties of lactic acid bacteria strains derived from canine feces

A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)

Hsa_circ_0002496 promotes the growth, angiogenesis, and stemness of breast cancer cells via miR‐433‐3p/YWHAZ cascade

Disitamab vedotin, a HER2‐directed antibody‐drug conjugate, in patients with HER2‐overexpression and HER2‐low advanced breast cancer: a phase I/Ib study

Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020

Suchergebnisse filtern